Balance Sheet Data

Heron Therapeutics, Inc. (HRTX)

$2.68

-0.03 (-1.11%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 172.38332.37390.97208.49157.58437.06654.83981.091,469.912,202.27
Total Cash (%)
Account Receivables 41.8764.6539.8841.8535.5087.46131.04196.33294.14440.70
Account Receivables (%)
Inventories 10.1139.0324.9741.9048.3853.0679.50119.10178.45267.35
Inventories (%)
Accounts Payable 18.9217.093.070.633.8023.7035.5053.1979.70119.40
Accounts Payable (%)
Capital Expenditure -2.55-9.17-7.15-6.810.48-8.40-12.59-18.87-28.27-42.35
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.